Translate:
Sign Up
TwitterFacebookLinkedin
Search
  • Dr. Brian Koffman’s Blog
More Links
CLL SocietyCLL Society
CLL Society
Patients and providers fighting CLL together
Smart Patients Get Smart Care™
Donate to CLL Society
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Test Before Treat™
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Paid Market Research Opportunities
    • Impact of Diagnosis
    • Taking Charge
    • Becoming Informed
    • Support
    • Caregivers
    • Planning Ahead
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Society Patient & Caregiver Educational Forums
    • The CLL Bloodline
    • Support Group Calendar
    • Support Group Contact
    • Leader Resources
    • CLL-Specific Patient Support Groups
    • Upcoming CLL Patient Education Programs
    • Archived Educational Activities
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • Ask & Tell
      • Ask The Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Menu back  

Search Results for: resistance

You are here:
  1. Home
  2. Results for "resistance"

ASH 2018: Kipps on Venetoclax Outcomes Including Resistance—The “Whack a Mole” Challenge

By Larry Marion Part one of two. Part two will be continued next week. Resistance is the scariest word in the English...
April 21, 20192018 ConferencesBy Brad Hedrick

ASH 2018: Professor Hillmen on Venetoclax Resistance in CLL

By Brian Koffman, MD ASH 2018: Professor Hillmen on Venetoclax Resistance in CLL (chronic lymphocytic leukemia) On the last day of ASH...
December 14, 20182018 ConferencesBy Brad Hedrick

ASH 2017: Dr. Adrian Wiestner on Resistance Mechanism in CLL (chronic lymphocytic leukemia)

I had the opportunity to interview Dr. Adrian Wiestner from the National Institutes of Health at ASH 2017 in Atlanta GA about...
July 30, 20182017 ConferencesBy Brian Koffman

ASH 2017: Professor Michael Hallek on Molecular Evolution in CLL and Venetoclax Resistance

At the ASH (American Society of Hematology) annual meeting in 2017 held in Atlanta, GA, I had the opportunity to...
June 12, 20182017 ConferencesBy Todd Dennison

ASH 2016: An Interview with Dr. George Follows on Late Resistance to Ibrutinib in CLL

At ASH 2016 Dr. George Follows of Cambridge, England discusses our evolving understanding of life after ibrutinib for those of...
June 27, 20172016 Conferences, Conference CoverageBy Brian Koffman

Beyond Ibrutinib Resistance in Chronic Lymphocytic Leukemia

Ibrutinib works amazingly well for most CLL patient by blocking BTK (Bruton’s tyrosine kinase), an enzyme that is overactive in...
April 18, 2017TreatmentBy Todd Dennison

ASH 2016: Dr. Neil Kay: Mechanism of Ibrutinib’s Resistance in CLL

In San Diego in December 2016 at the annual American Society of Hematology ASH) meeting, I interviewed Dr. Neil Kay...
February 21, 20172016 ConferencesBy Todd Dennison

ASH 2015: Dr. Stephan Stilgenbauer on Resistance to Ibrutinib in CLL

In the second part of three interviews from the 2015 American Society of Hematology annual meeting with Dr. Stephan Stilgenbauer...
March 6, 20162015 ConferencesBy Todd Dennison

CRC 2015: Ibrutinib Resistance, Drug Combos, and Treating Asymptomatic CLL

In our wide-ranging interview from the CRC (Chronic Lymphocytic Leukemia Research Consortium) meeting in April 2015, we look at how...
October 19, 20152015 ConferencesBy Todd Dennison

ASH 2014: Dr. Jan Burger on Ibrutinib Resistance in CLL

Dr. Jan Burger from the MD Anderson Cancer Center spoke to me about his research on ibrutinib resistance in chronic...
May 18, 20152014 ConferencesBy Todd Dennison
12345…
678
9
Next page
  • Home
  • Basics
    • Basic Terms
    • Getting Started
    • Test Before Treat™
    • Early Care
    • Treatment
    • Cake of Cure for CLL
    • CLL Comic Book
    • CLL FAQs
  • Beyond The Basics
    • CLL Overview by Dr. Kipps
    • Richter’s Transformation
    • CAR-T and Other Cellular Therapies
    • Treatment
    • What About CT Scans?
    • How is Treatment Selected?
    • Advanced Prognostics
  • Living Well With CLL
    • Paid Market Research Opportunities
    • Impact of Diagnosis
    • Taking Charge
    • Becoming Informed
    • Support
    • Caregivers
    • Planning Ahead
  • Clinical Trials
    • The Basics
    • The Patient Perspective
    • News about Clinical Trials
  • Conference Coverage
    • 2019 Conferences
    • 2018 Conferences
    • Past Years
      • 2017 Conferences
      • 2016 Conferences
      • 2015 Conferences
      • 2014 Conferences
      • 2013 Conferences
    • Links To Blog Conference Coverage
  • CAR-T
  • Support Groups/Education
    • CLL Society Patient & Caregiver Educational Forums
    • The CLL Bloodline
    • Support Group Calendar
    • Support Group Contact
    • Leader Resources
    • CLL-Specific Patient Support Groups
    • Upcoming CLL Patient Education Programs
    • Archived Educational Activities
  • News
    • CLL Society in the News
    • The CLL Society Tribune
      • Ask & Tell
      • Ask The Doctor
      • Ask The Pharmacist
      • Did You Know?
    • Business, Finances, Insurance & Regulatory
    • Official Statements and Press Releases
    • Clinical
    • CLL Society Alerts
  • About Us
    • Contact
    • Mission & Vision
    • Board of Directors
    • Medical Advisory Board
    • Patient Advisory Board
    • The CLL Society Staff
    • The Orange County CLL Support Group
    • Volunteer With Us!
Navigation
We’d like to thank our supporters:
  • AbbVie
  • AstraZeneca
  • Beigene
  • Celgene
  • Genentech/Biogen Idec
  • Gilead
  • Juno
  • Pharmacyclics/Janssen
  • Sunesis Pharmaceuticals
  • TG Therapeutics
  • Verastem
Copyright 2019 CLL Society, Inc. All Rights Reserved.
Terms & Conditions | Privacy Policy





Social media & sharing icons powered by UltimatelySocial
This site uses cookies: Find out more.